Implication and roles of infectious agents in the formation of the atheromatous plaque. Infection and atherosclerosis;Implication et modes d'action des agents infectieux dans la formation de la plaque d'athérome. Infection et athérosclérose

Pathologie Biologie

Volumn 49, Issue 10, 2001, Pages 824-829

  Lizard, G ^a   Gambert, P ^a  

^a HÔPITAL DU BOCAGE   (France)

Author keywords

Atherosclerosis; Chlamydia pneumoniae; Coxsakievirus; Cytomegalovirus; Helicobacter pylori; Hepatitis A virus; Herpes simplex virus; Infectious agents; Marek's disease virus; Porphyromonas gingivalis; Streptococcus sanguis

Indexed keywords

ARTICLE; ATHEROMA; ATHEROSCLEROTIC PLAQUE; AVIAN LYMPHOMATOSIS HERPETOVIRUS; CELL PROLIFERATION; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; COXSACKIE VIRUS B; CYTOMEGALOVIRUS; FIBROBLAST; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HEPATITIS A VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PORPHYROMONAS GINGIVALIS; STREPTOCOCCUS SANGUINIS; VASCULAR SMOOTH MUSCLE; VIRUS INFECTION;

EID: 0035195772     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0369-8114(01)00224-3     Document Type: Short Survey

References (62)

1. Enterovirus infection as a possible risk factor for myocardial infarction
2. Analytical sensitivity, reproducibility of results, and clinical performance of five PCR assays for detecting Chlamydia pneumoniae DNA in peripheral blood mononuclear cells
3. Multiple infections in carotid atherosclerotic plaques
4. CMV and transplant-related coronary atherosclerosis: An immunohistochemical, in situ hybridization, and polymerase chain reaction in situ study
5. Herpesvirusinduced atherosclerosis in chickens
6. Chlamydia pneumoniae-induced atherosclerosis in a rabbit model
7. Lessons from sudden coronary death. A comprehensive morphological classification scheme for atherosclerotic lesions
8. Atherosclerosis - An inflammatory disease
9. Disease of the arteries
10. The relation between acute infectious diseases and arterial lesions
11. Arteriosclerosis and cardiovascular disease: Their relation to infectious diseases
12. Virus-induced atherosclerosis
13. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery
14. Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels
15. The relation between Chlamydia pneumoniae and atherosclerosis
16. Relationship of Chlamydia pneumoniae infection to severity of human coronary atherosclerosis
17. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The azithromycin in coronary artery disease. Elimination of myocardial infection with chlamydia (ACADEMIC) study
18. No evidence for the presence of Helicobacter pylori in atherosclerotic plaques in abdominal aortic aneurysm specimens
19. Lack of association between Helicobacter pylori infection and extracardiac atherosclerosis in dyspeptic elderly subjects
20. The role of Helicobacter pylori in cardiovascular and cerebrovascular diseases
21. Helicobacter pylori: From the stomach to the heart
22. Dental plaque, platelets, and cardiovascular diseases
23. Oral pathogens: From dental plaque to cardiac disease
24. Invasion of human coronary artery cells by periodontal pathogens
25. Atheroarteriosclerosis induced by infection with a herpes virus
26. Infections and atherosclerosis
27. Cytomegalovirus and atherosclerosis
28. Altered cholesteryl ester cycle is associated with lipid accumulation in herpesvirus-infected arterial smooth muscle cells
29. Virus-induced atherosclerosis. Herpesvirus infection alters aortic cholesterol metabolism and accumulation
30. Virus infection of endothelial cells
31. Cytomegalovirus infection and atherosclerosis
32. Association between prior cytomegalovirus infection and the risk of restenosis after coronary arterectomy
33. Herpes simplex virus and atherosclerosis
34. Evidence of type-2 herpes simplex infection in human coronary arteries at the time of coronary artery bypass surgery
35. Infection and coronary heart disease
36. Coxsackievirus group B replication in cultured fetal baboon aortic smooth muscle cells
37. Cardiovascular lipid accumulation with Coxsackie B virus infection in mice
38. Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression
39. The procoagulant response of cytomegalovirus infected endothelial cells
40. The immediate early gene products of human cytomegalovirus increase vascular smooth muscle cell migration, proliferation, and expression of PDGFβ-receptor
41. Effects of human cytomegalovirus immediate-early proteins on apoptosis in coronary artery smooth muscle cells
42. Inhibition of apoptosis in Chlamydia-infected cells: Blockade of mitochondrial cytochrome c release and caspase activation
43. Human cytomegalovirus increases modified low density lipoprotein uptake and scavenger mRNA expression in vascular smooth muscle cells
44. Up-regulation of LFA-3 and ICAM-1 on the surface of fibroblasts infected with cytomegalovirus
45. Production of basic fibroblast growth factor and interleukin-6 by human smooth muscle cells following infection with Chlamydia pneumoniae
46. Helicobacter pylori and chronic immune activation
47. Infection and inflammation induce LDL oxidation in vivo
48. Cross anfigenicity between human arterial tissue and various germs
49. Experimental immune arteriosclerosis in the rabbit. Immunogenic and pathogenic properties of glycoproteins and elastins in arterial tissue
50. Prevention by calcitonin of pathological modifications of the rabbit arterial wall induced by immunization with elastin peptides: Effect on vascular smooth muscle permeability to ions
51. Cytomegalovirus infection of rats increases the neointimal response to vascular injury without consistent evidence of direct infection of the vascular wal
52. Chlamydia infection and heart disease linked through antigenic mimicry
53. Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae: Immune reaction to heat shock proteins as a possible link between infection and atherosclerosis
54. Phylogenic analysis of the stress-70 protein family
55. The role of oxidized lipoproteins in atherosclerosis
56. Different patterns of IL-1β secretion, adhesion molecule expression and apoptosis induction in human endothelial cells treated with 7α-7 β-hydroxycholesterol, or 7-ketocholesterol
57. Inflammation, infection, or both in atherosclerosis: The ROXIS trial in perspective
58. Inflammation, infection and atherosclerosis: Do antibacterials have a role in the therapy of coronary artery disease?
59. The role of adaptative immunity in atherosclerosis
60. Current, new and future treatments in dyslipidemia and atherosclerosis
61. How to design vaccination trial to prevent atherosclerosis